Chiral resolution of the epoxyeicosatrienoic acids, arachidonic acid epoxygenase metabolites

Analytical Biochemistry

Volumn 352, Issue 1, 2006, Pages 129-134

  Wei, Shouzou ^a   Brittin, James J ^a   Falck, John R ^b   Anjaiah, Siddam ^b   Nithipatikom, Kasem ^c   Cui, Lijie ^c   Campbell, William B ^c   Capdevila, Jorge H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arachidonic acid epoxygenase; Chiral analysis; EETs; Endogenous EETs; Epoxyeicosatrienoic acids; P450 epoxygenase

Indexed keywords

BIOCHEMISTRY; STEREOCHEMISTRY; UNSATURATED FATTY ACIDS;

ARACHIDONIC ACIDS; CHIRAL ANALYSIS; EETS; ENDOGENOUS EETS; EPOXYEICOSATRIENOIC ACIDS; P450 EPOXYGENASE;

METABOLITES;

ARACHIDONIC ACID EPOXYGENASE; CYTOCHROME P450; ENZYME; EPOXYICOSATRIENOIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHIRALITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 33646065988     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.01.005     Document Type: Article

References (24)

1. Spector A.A., Fang X., Snyder G.D., and Weintraub N.L. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog. Lipid Res. 43 (2004) 55-90
2. Sacerdoti D., Gatta A., and McGiff J.C. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. Prostaglandins Other Lipid Mediat. 72 (2003) 51-71
3. Zhao X., and Imig J.D. Kidney CYP450 enzymes: biological actions beyond drug metabolism. Curr. Drug Metab. 4 (2003) 73-84
4. Campbell W.B., and Gauthier K.M. What is new in endothelium-derived hyperpolarizing factors. Curr. Opin. Nephrol. Hypertens. 11 (2002) 177-183
5. Capdevila J.H., and Falck J.R. Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. Prostaglandins Other Lipid Mediat. 68/69 (2002) 325-344
6. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 (2002) 131-185
7. McGiff J.C., and Quilley J. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr. Opin. Nephrol. Hypertens. 10 (2001) 231-237
8. Capdevila J.H., Karara A., Waxman D.J., Martin M.V., Falck J.R., and Guengerich F.P. Cytochrome P450 enzyme specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J. Biol. Chem. 265 (1990) 10865-10871
9. Karara A., Dishman E., Falck J.R., and Capdevila J.H. Endogenous epoxyeicosatrienoyl-phospholipids: a novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J. Biol. Chem. 266 (1991) 7561-7569
10. Zeldin D.C., Kobayashi J., Falck J.R., Winder B.S., Hammock B.D., Snaper J.R., and Capdevila J.H. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268 (1993) 6402-6407
11. Yu Z., Xu F., Huse L.M., Morisseau C., Draper A.J., Newman J.W., Parker C., Graham L., Engler M.M., Hammock B.D., Zeldin D.C., and Kroetz D.L. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ. Res. 87 (2000) 992-998
12. Sinal C.J., Miyata M., Tohkin M., Nagata K., Bend J.R., and Gonzalez F.J. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J. Biol. Chem. 275 (2000) 40504-40510
13. Hammonds T.D., Blair I.A., Falck J.R., and Capdevila J.H. Resolution of epoxyeicosatrienoates enantiomers by chiral phase chromatography. Anal. Biochem. 182 (1989) 300-303
14. Karara A., Dishman E., Blair I.A., Falck J.R., and Capdevila J.H. Endogenous epoxyeicosatrienoic acids: cytochrome P450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J. Biol. Chem. 264 (1989) 19822-19827
15. Nithipatikom K., Grall A.J., Holmes B.B., Harder D.R., Falck J.R., and Campbell W.B. Liquid chromatography-electrospray ionization mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal. Biochem. 298 (2001) 327-336
16. Moustakis C.A., Viala J., Capdevila J., and Falck J.R. Total synthesis of the cytochrome P-450 epoxygenase metabolites 5(R),6(S)-, 5(S),6(R)-, and 14(R),15(S)-epoxyeicosatrienoic acid (EET) and hydration products 5(R),6(R)- and 14(R),15(R)-dihydroxyeicosatrienoic acid (DHET). J. Am. Chem. Soc. 107 (1985) 5283-5285
17. Falck J.R., Reddy Y.K., Haines D.C., Reddy K.M., Krishna U.M., Graham S., Murry B., and Peterson J.A. Practical, enantiospecific syntheses of 14,15-EET and leukotoxin B (vernolic acid). Tetrahedron Lett. 42 (2001) 4131-4133
18. Mosset P., Yadagiri P., Lumin S., Capdevila J., and Falck J.R. Arachidonate epoxygenase: total synthesis of both enantiomers of 8,9- and 11,12-epoxyeicosatrienoic acid. Tetrahedron Lett. 27 (1986) 6035-6038
19. Falck J.R., Yadagiri P., and Capdevila J.H. Synthesis of epoxyeicosatrienoic acids and heteroatom analogs. Methods Enzymol. 187 (1990) 357-364
20. Capdevila J.H., Falck J.R., Dishman E., and Karara A. Cytochrome P450 arachidonate oxygenase. Methods Enzymol. 187 (1990) 385-394
21. Capdevila J.H., Dishman E., Karara A., and Falck J.R. Cytochrome P450 arachidonic acid epoxygenase: stereochemical characterization of epoxyeicosatrienoic acids. Methods Enzymol. 206 (1991) 441-453
22. Yang W., Gauthier K.M., Reddy M., Sangras B., Sharma K.K., Nithipatikom K., Falck J.R., and Campbell W.B. Stable 5,6-epoxyeicosatrienoic acid analog relaxes coronary arteries through potassium channel activation. Hypertension 45 (2005) 681-686
23. Piras P., Roussel C., and Pierrot-Sanders J. Reviewing mobile phases used on Chiralcel OD through an application of data mining tools to CHIRBASE database. J. Chromatogr. 906 (2001) 443-458
24. Wang H., and Negishi M. Transcriptional regulation of cytochrome P450 2B genes by nuclear receptors. Curr. Drug Metab. 4 (2003) 515-525